It is widely accepted that elevated levels of lipoprotein (a)(Lp (a)) are associated with an
increased risk for cardiovascular diseases. Several studies have identified Lp (a) as …

Abstract Lipoprotein (a)[Lp (a)] became besides LDL cholesterol one of the most attractive
targets for intervention in cardiovascular disease. Strong genetic evidence supports the …

Background Elevated plasma (Lp (a)) levels may represent an independent risk factor for
atherothrombotic complications but the relation between Lp (a) levels and the extent of …

Abstract Lipoprotein (a)[Lp (a)] is an atherogenic lipoprotein with a strong genetic regulation.
Up to 90% of the concentrations are explained by a single gene, the LPA gene. The …

Aims In view of the consolidating evidence on the causal role of Lp (a) in cardiovascular
disease, the Italian Society for the Study of Atherosclerosis (SISA) has assembled a …

Although in vitro studies support a pathophysiologic role for lipoprotein (a)[Lp (a)] in the
development of atherosclerosis, and retrospective studies consistently report that there is a …

Lipoprotein (a)(Lp (a)) is a low density lipoprotein-like particle in which apolipoprotein B100
is covalently linked to the unique apolipoprotein (a). There is a mounting body of evidence …

Abstract Lipoprotein (a)[Lp (a)] is composed of a low density lipoprotein (LDL)-like particle to
which apolipoprotein (a)[apo (a)] is linked by a single disulfide bridge. Lp (a) is considered a …

Despite more than 3 decades of intense scientific research that has fostered our
understanding of the structure and biochemistry of lipoprotein (a)[Lp (a)], the …

Background: Increased plasma lipoprotein (a)[Lp (a)] concentrations have been reported to
be an independent risk factor for coronary heart disease (CHD) in some prospective studies …